ARCHIVES

Large, Conclusive Trials Provide Answers To Treatment Questions For GI Cancers

This article is from The Cancer Letter archive.

Vol. 32 No. 6 | June 26, 2009

Download PDF Visit The Full Archive

Related Articles

NCAB Hung Up On removing $ 45 Million Limit For Core Grants

September 17, 1976

Post Starts Series With Horror Stories On Drug Testing; DeVita Says They Are “Slanted, Distorted”

October 23, 1981

Analysis Reveals CAIX Subgroup Responsive to Rencarex Therapy

June 28, 2013

News In Brief: ACS Abandons Plan To Cut Local, Unit Boards Of Directors

October 9, 1998

Eight Scientists Receive $800,000 From Milken

January 5, 1990

Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial.

March 1, 2002